Serum Ferritin and Prognosis of DKA

Recruiting

• Conditions: Diabetic Ketoacidosis

• Registration Number: NCT06748365
• Lead Sponsor: Sohag University

Brief Summary

the aim of this study is to: evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value in predicting short-term outcomes.

Detailed Description

Ferritin studies and correlation to acute events like stroke or Mi was done before, however some studies have found a correlation with the degree and prognosis of these diseases and others not. However no study was tried on DKA patients before so the investigators are trying to find if Ferritin would have a relation with patients of Dka and could be used as a prognostic tool (for example we found in this study when level is less than "200" patients mostly has good prognosis) this is just an example or (serrum ferritin turned out to be irrelevant to DKA prognosis as patients would have good prognosis despite number value) and this will be in selected patients according to criteria to exclude any chronic condition in the investigators hospital care units.

Study Timeline

• Status Verified: 2024-12
• Study First Submitted: 2024-12-18
• Study First Submitted QC: 2024-12-21
• Study First Posted: 2024-12-27
• Study Start: 2025-01-01
• Last Update Submitted: 2025-05-08
• Last Update Posted: 2025-05-14
• Primary Completion: 2026-01
• Study Completion: 2026-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All patients with DKA :

1. Adult Aged 18 years old or older .
2. Type 1 DM , type 2 DM
3. Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <18 mEq/L,

Exclusion Criteria

1. Patients age less than 18 years old
2. Iron deficiency anemia and iron overload
3. Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease
4. Acute and chronic infections, including bacterial, viral, and fungal infections
5. Pt presented with other acute complication (MI,stroke)
6. CKD patients
7. Patients with chronic liver diseases
8. Patients with malignancy
9. Pregnant women.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value	Through the study completion, an average of 1 year

Trial Locations

Locations (1)

Sohag university Hospitals; 🇪🇬 Sohag, Egypt